× Didn't find what you were looking for? Ask a question
Top Posters
Since Sunday
c
5
j
5
a
5
L
5
f
5
j
5
D
4
k
4
y
4
t
4
h
4
l
4
New Topic  
Nrobison2016 Nrobison2016
wrote...
Posts: 318
Rep: 0 0
6 years ago
A patient will receive intrathecal liposomal cytarabine (DepoCyt) to treat acute myelogenous leukemia. The provider has ordered the concurrent administration of dexamethasone. The nurse understands that this is given to:
 
  a. prevent bone marrow suppression.
  b. prevent hair loss and stomatitis.
  c. reduce the incidence of pulmonary edema.
  d. reduce the severity of chemical arachnoiditis.
Read 33 times
2 Replies

Related Topics

Replies
wrote...
6 years ago
ANS: D
Chemical arachnoiditis can occur with the liposomal formulation of cytarabine; dexamethasone is given to reduce the incidence and severity of this side effect. It is not used to prevent bone marrow suppression. It is not given to minimize hair loss or stomatitis. It does not reduce the incidence of pulmonary edema.
Nrobison2016 Author
wrote...
6 years ago
This helps so much, thank you for responding
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers
  922 People Browsing
 101 Signed Up Today
Related Images
  
 371
  
 279
  
 321
Your Opinion
What's your favorite math subject?
Votes: 315